BUSINESS NEWS

AstraZeneca gets DGCI approval for import and marketing of Selumetinib capsules

Written by admin

AstraZeneca gets DGCI approval for import and marketing of Selumetinib capsules

New Delhi, Sep 26 (PTI) Drug maker AstraZeneca Pharma India on Sunday said it has received approval from the Drug Regulatory Agency of India for import and marketing of Selumetinib capsules.

AstraZeneca Pharma India said in a regulatory document that the company has received permission from the Drug Controller General of India (DCGI) in Form CT-20 for import and marketing of Selumetinib 10 mg and 25 mg capsules.

The company said that with this approval, the way for Selumetinib 10 mg and 25 mg capsules to be available in India will be cleared.

#AstraZeneca #DGCI #approval #import #marketing #Selumetinib #capsules

Rate this Article
See also  TRAI issues consultation paper on market structure competition in cable TV sector - trai issues consultation paper on market structure competition in cable TV sector

About the author

admin

Leave a Comment

close
%d bloggers like this: